Abiopharma

🔍 MOELLER PETER D (Executive)

Company: TORO CO (TTC)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Common Stock at $56.54 per share (Direct)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,668.25 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,320 shares of Common Stock at $93.4 per share (Direct)
  Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,348.25 | transaction_form_type: 4
• Sold 100 shares of Common Stock at $93.408 per share (Direct)
  Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,248.25 | transaction_form_type: 4
• Sold 100 shares of Common Stock at $93.41 per share (Direct)
  Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,148.25 | transaction_form_type: 4
• Sold 480 shares of Common Stock at $93.45 per share (Direct)
  Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 668.25 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-11 | Code: H | nature_of_ownership: Moeller Family Trust | shares_owned_after: 6,259.91 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-11 | Code: H | nature_of_ownership: The Toro Company Retirement Plan | shares_owned_after: 4,211.02 | Footnotes: F3
• Holds 0 shares of Performance Share Units (Direct)
  Date: 2026-06-11 | Code: H | shares_owned_after: 3,186.95 | Footnotes: F4
• Sold 2,000 shares of Non-Qualified Stock Option at $56.54 per share (Derivative)
  Date: 2026-06-11 | Code: M | Expires: 2026-12-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5
• Holds 2,645 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 2,644.51 | Footnotes: F6, F7, F7
• Holds 20,805 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 20,804.91 | Footnotes: F6, F8, F8

Footnotes:

• F1: Includes 2.663 shares of common stock acquired by the reporting person since the date of his last report under a dividend reinvestment feature of the account in which the shares are held.
• F2: Includes 24.941 shares of common stock acquired by the reporting person since the date of his last report under a dividend reinvestment feature of the account in which the shares are held.
• F3: Includes 16.854 net shares acquired by the reporting person since the date of his last report under the dividend reinvestment feature of The Toro Company Retirement Plan less quarterly non-discretionary administrative fees.
• F4: Includes 12.762 performance share units acquired by the reporting person since the date of his last report under the dividend reinvestment feature of The Toro Company Deferred Compensation Plan for Officers.
• F5: The option vests in three equal annual installments commencing on the first anniversary of the December 9, 2016 grant date.
• F6: Each restricted stock unit represents a contingent right to receive one share of TTC common stock.
• F7: The restricted stock units vest in three equal annual installments commencing on the first anniversary of the December 22, 2025 grant date.
• F8: The restricted stock units vest in full on October 10, 2028, which is the third anniversary of the date of grant.